162 related articles for article (PubMed ID: 17673926)
1. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Deng L; Broaddus RR; McCampbell A; Shipley GL; Loose DS; Stancel GM; Pickar JH; Davies PJ
Clin Cancer Res; 2005 Dec; 11(23):8258-64. PubMed ID: 16322283
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
5. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.
Xie R; Schlumbrecht MP; Shipley GL; Xie S; Bassett RL; Broaddus RR
Lab Invest; 2009 Aug; 89(8):937-47. PubMed ID: 19506550
[TBL] [Abstract][Full Text] [Related]
6. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
7. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
8. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
9. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma.
Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU
Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855
[TBL] [Abstract][Full Text] [Related]
11. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.
Orlandi A; Ferlosio A; Ciucci A; Francesconi A; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
Mod Pathol; 2006 Jun; 19(6):797-803. PubMed ID: 16575402
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of clusterin according to histological type of endometrial carcinoma.
Ahn HJ; Bae J; Lee S; Ko JE; Yoon S; Kim SJ; Sakuragi N
Gynecol Oncol; 2008 Aug; 110(2):222-9. PubMed ID: 18514801
[TBL] [Abstract][Full Text] [Related]
13. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
[TBL] [Abstract][Full Text] [Related]
14. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.
Rosty C; Ueki T; Argani P; Jansen M; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Am J Pathol; 2002 Jan; 160(1):45-50. PubMed ID: 11786397
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of cancer antigen in uterine cancers.
Nur S; Chuang L; Ramaswamy G
Int J Gynecol Cancer; 2006; 16(5):1903-10. PubMed ID: 17009990
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
18. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
[TBL] [Abstract][Full Text] [Related]
19. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer.
Rehman I; Goodarzi A; Cross SS; Leiblich A; Catto JW; Phillips JT; Hamdy FC
Prostate; 2007 Mar; 67(4):341-7. PubMed ID: 17219414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]